Hematopoietic stem cell-derived myeloid and plasmacytoid DC-based vaccines are highly potent inducers of tumor-reactive T cell and NK cell responsesex vivo-Reference-Cited by-同舟云学术

Hematopoietic stem cell-derived myeloid and plasmacytoid DC-based vaccines are highly potent inducers of tumor-reactive T cell and NK cell responsesex vivo

Published:2017-02-06 Issue:3 Volume:6 Page:e1285991
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Thordardottir Soley¹,Schaap Nicolaas²,Louer Elja¹,Kester Michel G. D.³,Falkenburg J. H. Frederik³^ORCID,Jansen Joop¹,Radstake Timothy R. D.⁴⁵,Hobo Willemijn¹,Dolstra Harry¹

Affiliation:

1. Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands

2. Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands

3. Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands

4. Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands

5. Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2017.1285991

Reference64 articles.

1. Haematopoietic cell transplantation as immunotherapy

2. Understanding and harnessing the graft-versus-leukaemia effect

3. The impact of the dose of natural killer cells in the graft on severe acute graft-versus-host disease after unrelated bone marrow transplantation

4. What Is the Role for Donor Natural Killer Cells after Nonmyeloablative Conditioning?

5. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation;Blood;2024-09-05

2. Efficient generation of human dendritic cells from iPSC by introducing a feeder-free expansion step for hematopoietic progenitors;2024-06-05

3. Therapeutic cancer vaccines: advancements, challenges, and prospects;Signal Transduction and Targeted Therapy;2023-12-13

4. Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation;Cancers;2023-04-08

5. LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy;Pharmaceutics;2022-12-08